🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“Covariants in KRAS/STK11 or KRAS/KEAP1 were associated with lack of pCR. Patients with single-station or multistation N2/N3 disease exhibited comparable pathological outcomes.” jamanetwork.com/journals/jamao… Biagio Ricciuti, MD, PhD Dana-Farber's Lowe Center for Thoracic Oncology JAMA Oncology #lcam #lcsm

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

American Cancer Society Matt Cooperberg Jonathan Evan Shoag 🇮🇱🇺🇸 Andrew Vickers Amer. Urol. Assn. ASCO ASTRO PCF Science Todd 〽️ Morgan, MD Edward Schaeffer, MD, PhD NRG Oncology Veracyte, Inc. Elai Davicioni Joe Biden Amar Kishan National Cancer Institute 15/x Summary: - President Biden’s physician followed the current USPSTF recommendation to not perform PSA screening in men >70yo - However, the USPSTF recommendations are flawed as PCa is common in men >70yo, is often more aggressive, if untreated men are more likely to die of

You’re in great hands America! Here are the 2025 Harvard/MIT MD-PhD graduates who have dedicated their lives to providing the best care to your families & delivering you medical cures from their groundbreaking science. NIH Jay Bhattacharya, MD, PhD HHS.gov Secretary Kennedy Harvard Medical School Massachusetts Institute of Technology (MIT)

Remarkable efforts to obtain on-treatment tissue to study TME. CRT with sequential pembro *might* be more favorable than concurrent pembro. ascopubs.org/doi/pdf/10.120… Sana Karam, MD, PhD Nadeem Riaz David Sher Aadel Chaudhuri, MD PhD Scott Bratman

Interview wirh Harvard University President⚠️ "The real question is, how much value does the federal government get from its expenditures on research? There is a lot of actual research demonstrating the returns to the American people have been enormous." 🙏 npr.org/2025/05/27/nx-…

Interesting data on some exceptional respones to Lu-PSMA in ATM-mutated cancers. In line with EBRT data.

Is 2025 YOUR year to win a Publication Excellence Award? Nominate yourself or a colleague at bit.ly/2025_PEA_nomin… to be recognized at the ASTRO Annual Meeting and win $1,500. Also accepting nominations for the ARRO Health Care Access Publication Award. #radonc

The peer-reviewed version of expansion in situ genome sequencing is now out in Science! The news is bittersweet – when we first revealed this last September, I never guessed it would be my final paper in academia, but a lot has changed. A few parting thoughts:

More than 200 new MDs and DMDs gathered with family, friends, and faculty to celebrate their graduation from Harvard Medical School and the Harvard School of Dental Medicine today. Congrats to our new physicians and dentists! bit.ly/3FwnRoT

In August 2024, 16-year-old Brady's life changed in an instant. After experiencing facial numbness and hearing loss, he was diagnosed with a rare brain tumor called a pilocytic astrocytoma. Though typically slow-growing, Brady’s tumor was large and inoperable due to its location.

Welcome to #ASCO25 ! On behalf of the🚨OncoAlert Network—hello from Chicago! 🌆 🔗 Sign up the Newsletter: oncoalert.m-pages.com/nhMpwe/oncoale… WE ARE ALL OncoAlert 🚨 For 7 years, we've brought you real-time updates from the biggest oncology congresses. This year, we’re back with: 🔹

What happens if #fluoride were removed from US water systems? A new study from Lisa Simon and collaborators predicts this decision could increase tooth decay in children and dental costs 🦷 💵 The study was published in JAMA Health Forum. Read more: massgeneralbrigham.org/en/about/newsr…

The times we find ourselves in Cutting the NIH—The $8 Trillion Health Care Catastrophe. #ScienceUnderSiege #sciencestrong jamanetwork.com/journals/jama-…

Dear Colleagues at #ASCO25 You are warmly invited to watch the Top Trials of the Year, presented by some of the world’s leading experts. All sessions are free and available on demand JUST CLICK AND WATCH ⭐ GU Oncology buff.ly/3hkYYG6 ⭐ #BreastCancer

Join this Wednesday, 6/4/25, ROBIN Cross Training Core Working Group Curriculum Lecture on “Cell Cycle Regulation/Response to Radiation Exposure” presented by Kathryn D. Held, PhD from Mass General Research Institute and Harvard Medical School. Message for Teams info.

Sophia Kamran, MD, MD, presenting her poster on radiation oncology for prostate cancer at #ASCO25.

🚨Thanks for the shout out! Specifically, we assembled a coalition of 7 institutions & pooled data looking at treatment specifics/outcomes for patients with oligometastatic prostate cancer who received RT (given that there is no consensus or guideline for management). #asco25

👀 #radonc - ☢️Should we be thinking of timing of #radiotherapy as a factor? Gerry Hanna Drew Moghanaki Henning Willers, MD, FASTRO Søren M Bentzen Ralph Weichselbaum